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Birth WeightAlthough considerable evidence suggests that in utero arsenic exposure affects children's health, these data are
mainly from areas of the world where groundwater arsenic levels far exceed the World Health Organization
limit of 10 μg/L. We, and others, have found that more common levels of in utero arsenic exposure may also
impact children's health. However, the underlying molecular mechanisms are poorly understood. To address
this issue, we analyzed the expression of key developmental genes in fetal placenta in a birth cohort of women
using unregulated water supplies in a US region with elevated groundwater arsenic. We identiﬁed several
genes whose expression associated with maternal arsenic exposure in a fetal sex-speciﬁc manner. In particular,
expression of the HEDGEHOG pathway component, GLI3, in female placentae was both negatively associated
with arsenic exposure and positively associated with infant birth weight. This suggests that modulation of
GLI3 in the fetal placenta, and perhaps in other fetal tissues, contributes to arsenic's detrimental effects on
fetal growth. We showed previously that arsenic-exposed NIH3T3 cells have reduced GLI3 repressor protein.
Together, these studies identify GLI3 as a key signaling node that is affected by arsenic, mediating a subset of
its effects on developmental signaling and fetal health.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Arsenic is a well-known toxic metalloid, and both a naturally occur-
ring and anthropogenic environmental contaminant (Hughes et al.,
2011). As such, arsenic levels are regulated in public drinking water
supplies in the US and other countries. In accordancewithWorld Health
Organization guidelines, the maximum contaminant level (MCL) for
arsenic set by the US Environmental Protection Agency (EPA) is
10 μg/L. However, in some parts of the world, arsenic contamination
of drinking water can reach several thousand micrograms per literartile range; MCL, maximum
oncentration;HH, HEDGEHOG.
pidemiology, Geisel School of
gy Program, DeWitt Daughtry
r School of Medicine, Miami, FL
(M.R. Karagas),
nal Human Genome Research
. This is an open access article under(Nordstrom, 2002). Ingestion of such highly contaminated water by
pregnantwomen, leading to in utero arsenic exposure of the developing
fetus, is associated with several adverse birth conditions, including low
birthweight (Huyck et al., 2007; Llanos and Ronco, 2009; Rahman et al.,
2009; Xu et al., 2011), increased risk of infection (Rahman et al., 2011),
and spontaneous abortion and infant mortality (Myers et al., 2010;
Sohel et al., 2010), as well as increased risk of certain diseases in later
life (reviewed in (Farzan et al., 2013)). Less is understood about lower
exposure levels, despite their relevance tomillions of peopleworldwide
(Nordstrom, 2002). Additionally, while there is evidence to suggest that
the response to in utero arsenic exposure varies by fetal sex (Hamadani
et al., 2011; Raqib et al., 2009; Xu et al., 2011), the molecular basis for
such differences is unknown. Therefore, there is an urgent need to
characterize the effects of in utero arsenic at common exposure levels,
in a manner that accounts for fetal sex, in order to prevent and treat
adverse health outcomes in at-risk populations. With this aim in mind,
the current study was performed on a cohort of pregnant women who
were exposed to arsenic in drinking water at levels that span above
and below the current US MCL.
Embryonic development is a highly regulated process that involves
numerous biological mechanisms, many of which are controlled bythe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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NOTCH and WNT (Clevers, 2006; Briscoe and Therond, 2013; Hori
et al., 2013). Cells receiving these signals undergo proliferation,
differentiation, and apoptosis, allowing the formation of sophisticated
structures and patterns. Activation of each of these signal transduction
cascades leads to the transcriptional regulation of a particular set of
target genes. These three signaling pathways are also involved in the
self-renewal of tissue-speciﬁc stem cells that drive organ development
and maintain tissue homeostasis in the adult. These stem cells often
exhibit high-level expression of “stemness” genes (Boiani and Scholer,
2005). During development, there are extensive cooperative and
antagonistic interactions between these pathways, which ultimately
determine cell fate.
In keepingwith their roles in cellular differentiation and embryogen-
esis, mutations in components of the HH, NOTCH orWNT pathways lead
to human developmental disorders. For example, holoprosencephaly
(HPE), a birth defect that affects the formation of midline structures
and causes facial defects including cleft lip, often results from loss-of-
function mutations in one allele of the HH family member SONIC
HEDGEHOG (SHH) (Belloni et al., 1996; Roessler et al., 1996). This
example underscores the susceptibility of humans to alterations in
the activity of these signaling pathways. Although severe disruptions
of these developmental pathways in humans likely lead to spontaneous
abortion, stillbirth, or distinct birth defects, more subtle alterations
in pathway activity, such as those resulting from environmental
exposures, may also perturb fetal development and impact long-term
health.
In this study of a US pregnancy cohort, we sought to identify piv-
otal developmental genes whose expression in fetal placenta associ-
ated with common levels of arsenic exposure. The placenta is a
specialized organ that is critical for normal fetal development and
survival. In addition, the fetal portion of the placenta shares its geno-
type and environment with the fetus proper, and so may be viewed
as a sentinel for the fetus that can be analyzed in a non-invasive
manner. We also examined the association of our candidate develop-
mental genes with infant birth weight, the outcome of fetal growth,
which is one important aspect of fetal development. We report
here that the placental expression of several key developmental
genes associates with in utero arsenic exposure, and further, that
many of these genes associate with arsenic in a fetal sex-speciﬁc
manner. Moreover, we found that expression of the HH pathway
gene GLI3was negatively associated with arsenic exposure but posi-
tively associated with birth weight among females. This observation
suggests a model whereby in utero arsenic exposure of the female
fetus results in reduced placental and possibly fetal GLI3 expression,
which in turn leads to reduced birth weight.Table 1
Study cohort demographic information.
Characteristic Mean
(SD)
Number
(%)
Median
(interquartile range)
Number of pregnant women 133 –
Gestational age (wks) 39.5 (1.6) – –
Maternal age at enrollment (yrs) 31.1 (4.6) – –
Parity 1.1 (1.1) – –
Pre-pregnancy BMI (kg/m2) 24.9 (4.7) – –
Smoking status during pregnancy
Never – 97 (72.9) –
Former – 13 (9.8) –
Current – 5 (3.8) –
Unknown – 18 (13.5) –
Number of infants – 133 –
Infant birth weight (kg) 3.4 (0.4) – –
Infant sex
Male – 65 (48.9) –
Female – 68 (51.1) –
Household water arsenic (μg/L) – – 0.36 (0.02–3.55)
Total urinary arsenic (U–As, μg/L) – – 4.4 (1.8–11.9)2. Materials and Methods
2.1. Study Design
The study cohort consisted of 133 pregnant women enrolled in
the ongoing New Hampshire Birth Cohort Study (NHBCS), which
began in January 2009 (Gilbert-Diamond et al., 2011). Eligibility
criteria have been described previously (Koestler et al., 2013). Brief-
ly, subjects were English-speaking, literate, mentally competent
women of 18–45 years of age with a singleton pregnancy, whose
home water supply was from a private well, and who had not
changed residence since their last menstrual period. Participants
provided written informed consent before enrolling in the study. De-
mographic data, pregnancy history and outcome, and lifestyle factor
information were collected from questionnaires and review of pre-
natal and delivery records. All research involving human partici-
pants has been approved by The Committee for the Protection of
Human Subjects at Dartmouth College.2.2. Sample Collection and Arsenic Measurement
Details of urine and household water sample collection and arsenic
measurement have been described previously (Koestler et al., 2013).
Brieﬂy, spot urine samples were collected at approximately 24–
28 weeks gestation and analyzed for individual arsenic species at the
University of Arizona using a high-performance liquid chromatography
inductively coupled plasmamass spectrometry (ICP-MS) system,with a
detection limit ranging from 0.10 to 0.15 μg/L for the individual arsenic
species. Measurements below the limit of detection were recorded as
themedian value between 0 μg/L and the detection limit for that arsenic
species. Total urinary arsenic concentration, U–As, was calculated by
summing the inorganic arsenic (iAs) species, arsenite (AsIII) and arse-
nate (AsV), plus dimethylarsinic acid (DMAV) and monomethylarsonic
acid (MMAV), and excluding arsenobetaine. Household water samples
were collected by the study participants using EPA-approved I-Chem
containers (VWR), and total arsenic concentration was analyzed by
ICP-MS at the Trace Element Analysis Core at Dartmouth. The detection
limit ranged from 0.009 to 0.074 μg/L.2.3. Placenta Biopsy and Gene Proﬁling
Placenta samples were obtained at the time of delivery. Biopsies
were taken at thebase of the umbilical cord insertion,measuring roughly
1 cmdeep to ensure the tissuewas of fetal origin, and 1–2 cm across, and
were immersed immediately in RNAlater (Life Technologies) and placed
at —80 °C for long-term storage. RNA extraction and subsequent gene
proﬁling were performed in three batches (44, 44 and 45 samples
respectively). Roughly 200 mg of placenta was homogenized in 1 ml Tri
Reagent (Molecular Research Center) using a motorized homogenizer,
and further puriﬁed using RNeasy mini columns (Qiagen). 100 ng of
high-quality RNA from each sample was subjected to gene expression
analysis using the Nanostring system (Nanostring Technologies) at
the Oncogenomics Core Facility of the University of Miami. The
Nanostring codeset was custom-designed for 29 development-related
genes, and 5 housekeeping genes (ATCB, GAPDH, HPRT1, RPL19, and
RPLP0) (Table 1). Two distinct probes were designed for GLI1 and
PTCH1 (GLI1/GLI1-2, PTCH1/PTCH1-2). Raw count data was ﬁrst
normalized to the spike-in positive and negative controls to account
for assay efﬁciency and then normalized to the geometric mean of
the expression of the 5 housekeeping genes using nSolver software
(Nanostring Technologies).
Table 2
Candidate genes for association with in utero arsenic exposure and birth weight.
HGNC gene symbol HGNC gene ID Classification
FOXA2 5022 Hedgehog pathway related 
genesGLI1 4317
GLI2 4318
GLI3 4319
HHAT 18270
IGF2 5466
IGFBP6 5475
PRPSAP1 9466
PTCH1 9585
PTCH2 9586
SPP1 11255
HES1 5192 Notch pathway related 
genesHES2 16005
HES5 19764
HEY1 4880
HEY2 4881
HEYL 4882
NOTCH1 7881
AXIN2 904 Wnt pathway related genes
DKK1 2891
LGR5 4504
PORCN 17652
SFRP1 10776
SFRP2 10777
WIF1 18081
BMI1 1066 Stemness genes
NANOG 20857
OLIG2 9398
POU5F1 9221
ACTB 132 Housekeeping genes
GAPDH 4141
HPRT1 5157
RPL19 10312
RPLP0 10371
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Gene expression data was ﬁrst batch-adjusted using the COMBAT
method (Johnson et al., 2007), which uses a location and scale adjust-
ment to standardize themean and variability in expression levels across
batches. Principal component analysis was then performed on the
batch-adjusted data to ensure that batch effects had been successfully
attenuated. Using the batch-adjusted data, a series of multivariable
linear regressionmodelswere used to examine the association between
U–As and gene expression for each of the candidate genes, as described
previously (Fei et al., 2013). Multivariable regression models were ﬁtted
to the cohort as awhole and after stratiﬁcationby infant sex.Wemodeled
log-transformed gene expression as a function of log-transformed U–As
and adjusted for maternal age at delivery. This adjustment was based
on analyses using a series of linear regression models to identify those
covariates that associated with arsenic exposure or birth weight,
among potential confounders, i.e., maternal age, maternal smoking
status (never, former, current), maternal education level, infant birth
weight, infant sex and gestational age. Unadjusted versions of all linear
regression analyses are provided in Table S4. As shown previously (Fei
et al., 2013), a power analysis indicated adequate statistical power for
detecting low-moderate correlations between U–As levels and gene
expression (absolute correlation (r) = 0.24; power = 80%) at a
signiﬁcance level of 0.05 and a study sample size of 133 subjects. All
aforementioned analyses were carried out using the R statistical
program, version 2.13 (http://cran.r-project.org/). Similar methods
were used to examine the associations of candidate gene expression
with infant birth weight, adjusting for maternal age and gestational
age, which were identiﬁed as confounders as described above.
2.5. Funding Sources
This publication was made possible by U.S. Environmental Protection
Agency (US EPA) grant RD-83544201,National Institute of Environmental
Health Sciences (NIEHS) grant P01 ES022832, a CTSA grant fromNCATS
awarded to the University of Kansas Medical Center for Frontiers:
The Heartland Institute for Clinical and Translational Research #
KL2TR000119 (DCK), and NIH grants R01GM081635 and
R01GM103926 (EL). Its contents are solely the responsibility of
the grantee and do not necessarily represent the ofﬁcial views of the
US EPA. Further, the US EPA does not endorse the purchase of any
commercial products or services mentioned in the publication. The
funding bodies did not play any role in the writing of the manuscript
or the decision to submit it for publication.
3. Results
3.1. Characteristics of the Study Cohort
The study cohort consisted of 133 mother–child pairs enrolled from
prenatal clinics in the state of New Hampshire, USA (Table 1). The
average age at the time of enrollment was 31.1 years and the average
gestational period was 39.5 weeks. Only a small percentage reported
smoking during pregnancy (5/133, 3.8%). Average pre-pregnancy body
mass index (BMI) was 24.9 kg/m2 and parity was 1.1. About half the
infants were male, and the average infant birth weight was 3.4 kg. The
median arsenic concentration in household tap water was 0.36 μg/L
(interquartile range [IQR] 0.02–3.55) and 16% of participants (21/133)
consumed drinking water containing arsenic at concentrations above
the current MCL of 10 μg/L. The median concentration of total urinary
arsenic (U–As), which includes all arsenic species except arsenobetaine,
was 4.4 μg/L (IQR 1.8–11.9). We found a strong association between
the participants' household water arsenic concentrations and urinary
arsenic concentrations, excluding arsenobetaine (Pearson correlation =
0.55, p-value b 0.001).3.2. Expression of GLI1 and POU5F1 in the Fetal Placenta is Associated with
Maternal Arsenic Exposure
We used maternal U–As as an estimate of arsenic exposure of the
fetus because it provides a reliable indication of arsenic concentration
in blood (Marchiset-Ferlay et al., 2012), and arsenic is known to readily
cross the placenta (Concha et al., 1998).Wemeasured the expression of
candidate genes in the fetal portion of the placenta to examine how
arsenic exposure might affect key developmental genes and signaling
pathways during fetal development. The gene list comprises key
components and consensus target genes of the HH, NOTCH, and WNT
pathways, and stem cell-related biomarkers (Table 2). As shown in
Fig. 1 (representative scatter plots in Fig. S1), U–As was signiﬁcantly
associatedwith the expression ofGLI1 (β:—0.11, 95% conﬁdence interval
[CI]: [—0.21, 0.00]) and POU5F1 (β:—0.04, 95% CI: [—0.09, 0.00]). A sec-
ond, sequence-distinct Nanostring probe for GLI1 (GLI1—2) also
displayed a signiﬁcant negative association with U–As (β: —0.07, 95%
CI: [—0.12, —0.01]). Based on the estimates from these multivariable
linear regression models, GLI1 and POU5F1 levels would be expected
to decrease 18% and 8%, respectively, between the 75th and 25th
percentiles of U–As levels.
3.3. Placental Expression of Key Developmental Genes Associates Sex-
speciﬁcally with Arsenic Exposure
Next, as arsenic-related toxicities are reported to exhibit sexually
dimorphic effects (Hamadani et al., 2011; Raqib et al., 2009; Xu et al.,
2011), we analyzed the associations of U–As with our candidate genes
after dividing the cohort into male and female subsets (Fig. 2). Interest-
ingly, many more of the candidate genes showed associations with
U–As among females than among males or the cohort as a whole.
Speciﬁcally, in males, only one gene, PORCN, was associated with U–As
(Fig. 2A; β:—0.197, 95% CI: [—0.383,—0.011]), while in females, the ex-
pression of LGR5,HES1,GLI1,GLI3 and POU5F1was negatively associated
with U–As, and IGFBP6 expression was positively associated (Fig. 2B;
Fig. 1. Associations between placental gene expression andmaternal U–As. Multivariable linear regression analyses were performed to determine the association betweenmaternal U–As
and placental gene expression. The analyses were adjusted for maternal age. GLI1/GLI1-2 and PTCH1/PTCH1-2 are sequence-distinct Nanostring probes designed to measure the
expression of GLI1 and PTCH1. Dots depict coefﬁcient estimates and error bars represent 95% CIs. Signiﬁcant associations are those with 95% CIs not crossing zero (dotted line) and are
marked by asterisks (*P b 0.05). Green; HH pathway-related genes, purple; NOTCH pathway-related genes, blue; WNT pathway-related genes, orange; stemness genes.
539E.F. Winterbottom et al. / EBioMedicine 2 (2015) 536–543coefﬁcient estimates and 95% CIs in Table S1). This observed sexual di-
morphism was not due to differential arsenic exposure, as maternal
U–As levels were not signiﬁcantly different for male versus femaleFig. 2. Sex-speciﬁc associations between placental gene expression andmaternal U–As.Multivar
by infant sex, to determine the association betweenmaternal U–As and placental gene expressio
Dots depict coefﬁcient estimates and error bars represent 95% CIs. Signiﬁcant associations are t
Green; HH pathway-related genes, purple; NOTCH pathway-related genes, blue; WNT pathwainfants (Fig. S2). Overall, this analysis indicates that a substantial num-
ber of key developmental genes are differentially affected by in utero ar-
senic exposure in male and female placentae. This suggests that thereiable linear regression analyseswere performed as in Fig. 1, after stratiﬁcation of the cohort
n in (A)male infants, and (B) female infants. The analyses were adjusted formaternal age.
hose with 95% CIs not crossing zero (dotted line) and are marked by asterisks (*P b 0.05).
y-related genes, orange; stemness genes.
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opment, a notion that is in agreement with existing literature
(Hamadani et al., 2011; Raqib et al., 2009; Xu et al., 2011).
3.4. Relationship between Maternal Arsenic Exposure and Infant Birth Weight
Previous studies have suggested that in utero arsenic exposure has
negative effects on infant birth weight (Huyck et al., 2007; Llanos and
Ronco, 2009; Rahman et al., 2009; Xu et al., 2011). In our cohort, we
previously reported an expected weight loss of 1.30 g per 1-μg/L
increase in U–As after adjustment for infant sex, maternal age and
gestational age (p-value = 0.33) (Fei et al., 2013). Further stratiﬁcation
by infant sex revealed a decrease in birth weight of 0.15 g per 1-μg/L in-
crease in U–As among males (p-value = 0.98), and a decrease in birth
weight of 1.5 g per 1-μg/L increase in U–As among females (p-
value = 0.21). While none of these associations reached statistical sig-
niﬁcance, probably due to insufﬁcient sample size, the birth weight
changes and trends in association with arsenic exposure in our cohort
are similar in scale to what has been reported previously (Rahman
et al., 2009; Hopenhayn et al., 2003).
3.5. Placental Expression of Key Developmental Genes Associates Sex-
speciﬁcally with Infant Birth Weight
We next examined whether the expression of our candidate genes
was associated with birth weight, in order to assess their potential
roles inmediating arsenic's effect on fetal growth.We performedmulti-
variable linear regression analysis to examine our set of candidate genesFig. 3. Sex-speciﬁc associations between placental gene expression and infant birth weight. Mu
infant sex, to determine the association between infant birthweight and placental gene express
and gestational age. Dots depict coefﬁcient estimates and error bars represent 95% CIs. Signiﬁc
asterisks (*P b 0.05, **P b 0.01). Green; HH pathway-related genes, purple; NOTCH pathway-refor associations with infant birth weight (Fig. S3). In the cohort as a
whole, birth weight was associated with the expression of three
genes: SFRP2, encoding a WNT pathway antagonist (β: 0.090, 95% CI:
[0.021, 0.160]); NOTCH1, encoding the NOTCH pathway receptor and
target gene (β: 0.285, 95% CI: [0.066, 0.503]); and GLI2, encoding a HH
pathway transcription factor (β: 0.301, 95% CI: [0.123, 0.480]). Similar
to the associations of gene expression with U–As, more signiﬁcant
associations of gene expression with birth weight were found after
stratifying the cohort by sex (Fig. 3). Among males, in addition to GLI2
and NOTCH1, expression of the HH target gene FOXA2 was positively
associated with infant birth weight, while expression of two genes
encoding stem cell regulators (BMI1 and NANOG), was negatively
associated with birth weight (Fig. 3A; coefﬁcient estimates and 95%
CIs in Table S2). Among females, expression of ﬁve genes (SFRP2,
LGR5, GLI3, SPP1 and BMI1) was positively associated with birth weight,
while expression of three genes (PORCN, IGF2 and SFRP1)was negatively
associated with birth weight (Fig. 3B; coefﬁcient estimates and 95% CIs in
Table S3). These data show that the placental expression of several genes,
encoding components of pivotal signaling pathways that drive early devel-
opment, is associated with birth weight in a sexually dimorphic manner.
3.6. Expression of GLI3 and LGR5 in the Female Fetal Placenta is Associated
with both Arsenic Exposure and Birth Weight
Finally, we compared the results of our sex-stratiﬁed multivariable
linear regression analyses for U–As (Fig. 2) and birth weight (Fig. 3) to
identify candidate genes that were signiﬁcantly associated with both
factors. In male placentae, no genes showed signiﬁcant association ofltivariable linear regression analyses were performed, after stratiﬁcation of the cohort by
ion for (A)male infants, and (B) female infants, after adjusting for maternal age at delivery
ant associations are those with 95% CIs not crossing zero (dotted line) and are marked by
lated genes, blue; WNT pathway-related genes, orange; stemness genes.
Fig. 4. GLI3 as a potential mediator of birth weight regulation by arsenic in female placentae. (A) Venn diagram showing genes signiﬁcantly associated with U–As and/or birth weight in
female placentae (Figs. 2B, 3B). LGR5 andGLI3 are both negatively associatedwith U–As andpositively associatedwith birthweight. (B)Model of GLI3 as an arsenic-responsive regulator of
birth weight.
541E.F. Winterbottom et al. / EBioMedicine 2 (2015) 536–543their expression with both U–As and birth weight. However, in female
placentae, expression of LGR5 and GLI3 was negatively associated with
U–As and positively associated with birth weight (Fig. 4A).
4. Discussion
In this study, we identiﬁed several key developmental and stem cell
regulatory genes as potential biomarkers of arsenic exposure in the fetal
placenta. Our results also revealed extensive sexual dimorphism in
the associations between placental gene expression and both in utero
arsenic exposure and infant birth weight. Particularly, we found that
expression of the HH pathway component, GLI3, in female placentae
was associated with both arsenic exposure and infant birth weight.
Combined with our previous results implicating GLI3 repressor protein
as a key arsenic target in cultured cells (Fei et al., 2010), these results
suggest that GLI3 may be a pivotal signaling node affected by arsenic
(Fig. 4B).
With respect to determining the molecular mechanisms underlying
arsenic's effects on children's health, our study has some limitations that
should be acknowledged. Firstly, this is a cross-sectional study, using
single measurements of U–As at mid-gestation, and placental gene
expression and infant weight at delivery. Therefore, this study was not
designed to identify cause-and-effect relationships. Additionally, the
chronological gap between the urinary arsenic measurement and analy-
ses of birthweight and placental gene expressionmay have led to inaccu-
rate assessment of arsenic exposure for some individuals, although
previous studies show that an individual's urinary arsenic concentration
is generally a reliable indicator of long-term exposure levels (Kile et al.,
2009; Navas-Acien et al., 2009). Finally, our study was performed on a
relatively small cohort and so was statistically underpowered to
measure the direct relationship between arsenic exposure and birth
weight, although the trend was similar to previous reports. Despite
these limitations, this study highlights possible genes and pathways
mediating arsenic's effects on fetal development and growth, providing
an important basis for future studies to conﬁrm the causative
relationships.
Arsenic exposure levels in our population were relatively low and
the gene expression changes we observed were also relatively subtle.
Nonetheless, even small variations in the expression of key develop-
mental pathway genes in utero could still impact fetal development
and growth by inﬂuencing placental function. Moreover, since arsenic
has been shown to readily pass across the placenta (Concha et al.,
1998), it is likely that the gene expression changes we observed in the
fetal placenta also occur in other fetal tissues, and directly inﬂuence
their development and growth. In our cohort, we observed arsenic-
associated reductions in the expression of the HH pathway target GLI1,
and the stem cell regulator, POU5F1. POU5F1 (also called OCT4) is acritical player in maintaining pluripotency of embryonic stem cells, and
its down-regulation is necessary for differentiation of the trophectoderm,
which ultimately forms the placenta (Nichols et al., 1998). Interestingly,
residual expression of POU5F1 is detected throughout the ﬁrst trimester
and in term placenta tissues, and reduction in this residual expression
is associated with gestational trophoblastic diseases (Zhang et al.,
2008). In the fetus, early loss of POU5F1 expression leads to preimplanta-
tion lethality (Nichols et al., 1998), and during later development,
POU5F1 is essential for convergent extension and primordial germ cell
survival (Kehler et al., 2004; DeVeale et al., 2013). The loss of one copy
of this gene, causing a reduction in expression of 30–40%, can induce
differentiation of embryonic stem cells in vitro (Nichols et al., 1998).
Thus, an 8% reduction in POU5F1 expression, which we observe in
response to arsenic exposure between the 25th and 75th quartiles of
U–As levels, may have multiple effects on fetal health.
Relatively little is known about the role of GLI1 in placenta biology.
However, in mice, several components of the HH pathway, including
all three HH ligands; SMO; PTCH1; and the transcription factors GLI2
and GLI3, are expressed abundantly in fetal placenta (Pan et al., 2015),
and disruption ofHHactivity causes severe placental defects, suggesting
essential roles in normal placental development and possibly pregnancy
maintenance (Pan et al., 2015; Jiang and Herman, 2006). Gli1 homozy-
gous null mice have reduced body weight, increased postnatal lethality,
and defects in T-cell development, while heterozygotes are of normal
weight but have reduced bone mass, reﬂecting the importance of
normal levels of GLI1 for bone homeostasis and immune function
(Kitaura et al., 2014; Drakopoulou et al., 2010). Moreover, a common
single nucleotide polymorphism (SNP) in human GLI1, which reduces
protein activity by around 50%, is associated, in both homozygous and
heterozygous states, with increased risk of inﬂammatory bowel disease
(Lees et al., 2008). Therefore, subtle changes in GLI1 expression, such as
the 18% reduction we observe in response to arsenic exposure between
the 25th and 75th quartiles of U–As levels, may have important conse-
quences for the fetus.
Interestingly, when we stratiﬁed our cohort by infant sex, more
genes showed an association with arsenic exposure, and many of
these associations were sexually dimorphic. In keeping with these
results, previous studies have suggested that in utero arsenic exposure
has differential effects on male and female infants. A study of a Chinese
population identiﬁed a negative relationship between maternal arsenic
exposure and birth weight among male, but not female infants (Xu
et al., 2011). Differences in susceptibility to infections have also been
noted, i.e. association of arsenic exposure with acute respiratory infec-
tions in male but not female children (Raqib et al., 2009). In addition,
a neurobehavioral study of children in Bangladesh found that the
adverse effects of in utero arsenic exposure on various IQ measures
were sex-speciﬁc (Hamadani et al., 2011). We also observed
542 E.F. Winterbottom et al. / EBioMedicine 2 (2015) 536–543considerable sexual dimorphism in the genes associated with birth
weight between males and females, suggesting that the primary genes
and pathways inﬂuencing birth weight may differ between the sexes,
as is supported by recent studies in both mouse and human (Delahaye
et al., 2014; Miranda et al., 2014). Of note, the IGF2, PORCN, SPP1,
and GLI3 genes, which are associated with birth weight among female
placentae in our cohort, have been previously linked to birth weight
variation in humans or animal models (Liu et al., 2012; Demetriou
et al., 2014; Allan et al., 2007; Huang et al., 2013; Martin et al., 2007).
Our ﬁndings suggest that infant sex is an important modifying factor
in examining gene regulation during development.
Among our candidate genes, we identiﬁed GLI3 as a potential
mediator of birth weight regulation by arsenic, being both negatively
associated with U–As and positively associated with birth weight in
female infants. GLI3 encodes a transcription factor that can act either
as a transcriptional activator or repressor depending on its proteolytic
status. We observed an arsenic-associated reduction in levels of both
GLI3 and the HH target GLI1 in female placentae, suggesting that GLI3
acts primarily as an activator of HH signaling in this tissue. Heterozy-
gous mutations in GLI3 lead to congenital disorders including Greig
cephalopolysyndactyly and Pallister–Hall syndrome (Naruse et al.,
2010), characterized by polydactyly, syndactyly, and head defects. The
Jackson extra-toes (XtJ) mouse, which expresses a non-functional splice
variant of GLI3, has similar defects (Buscher et al., 1998; Maynard et al.,
2002), and interestingly, heterozygous XtJ mice have increased birth
weight compared to wild-type mice (Martin et al., 2007). In the
mouse placenta, knockdown of GLI3 partially rescues abnormal
branching of the placental labyrinth caused by SHH knockout (Pan
et al., 2015), suggesting that GLI3 controls placental morphogenesis by
repressing SHH targets. While these mouse studies suggest that GLI3
negatively regulates HH signaling in the placenta and fetal growth,
which contrasts with the positive regulation suggested by our ﬁndings,
thismay be explained by sex- or species-speciﬁc differences or compen-
satory mechanisms. In addition, a recent study in cattle identiﬁed two
synonymous SNPs in GLI3 that were associated with increased birth
weight in both homozygous and heterozygous states (Huang et al.,
2013). Together, these studies raise the possibility of a conserved role
forGLI3 in fetal growth regulation, and suggest that even subtle changes
in its expression may impact birth weight. We previously showed that
chronic exposure of NIH3T3 cells to arsenic reduced levels of GLI3
repressor protein and concomitantly increased HH pathway activity
(Fei et al., 2010). Together with our current ﬁndings, this suggests that
modulation of GLI3, both at the transcriptional and post-transcriptional
levels, provides an important means by which arsenic affects various
human pathologies.
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